The next generation of test-to-treat diagnostics is here, and we’re on a mission to make healthcare accessible to all.
Lucira was the proud provider for COVID-19 testing for the RTCA for their annual dinner in Washington, D.C this past March.
As of January 15, private insurance companies are required to reimburse members for at-home COVID-19 test purchases. Read and learn how to obtain your reimbursement.
Learn what we know so far about Omicron’s subvariant BA.2. Read the blog now to stay informed.
This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
For general media inquiries, please contact Lucira@luckybreakpr.com. If your media request is urgent, please contact: Mike Stommel at mike@luckybreakpr.com
Monday – Sunday 4:30am-2:00am PT
